First Data Sharing Agreement signed with external data contributor Active Biotech AB. Active Biotech AB has now shared data collected in a phase 3 randomised, double blind, placebo controlled study of tasquinimod in men with metastatic castrate-resistant prostate cancer. The data from 411 men was collected between 2011 and 2015 and has been shared to the PIONEER platform using the Central data sharing model. This brings to eight the total number of datasets now available in the PIONEER platform. Interested in contributing data to PIONEER? Contact us at firstname.lastname@example.org.